These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36843560)

  • 21. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
    Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
    Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macroglossia and less advanced dystrophic change in the tongue muscle of the Duchenne muscular dystrophy rat.
    Yamanouchi K; Tanaka Y; Ikeda M; Kato S; Okino R; Nishi H; Hakuno F; Takahashi SI; Chambers J; Matsuwaki T; Uchida K
    Skelet Muscle; 2022 Oct; 12(1):24. PubMed ID: 36258243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
    Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
    Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal NFAT5 Physiology in Duchenne Muscular Dystrophy Fibroblasts as a Putative Explanation for the Permanent Fibrosis Formation in Duchenne Muscular Dystrophy.
    Herbelet S; De Paepe B; De Bleecker JL
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in genetic therapeutic strategies for Duchenne muscular dystrophy.
    Guiraud S; Chen H; Burns DT; Davies KE
    Exp Physiol; 2015 Dec; 100(12):1458-67. PubMed ID: 26140505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy.
    Galindo CL; Soslow JH; Brinkmeyer-Langford CL; Gupte M; Smith HM; Sengsayadeth S; Sawyer DB; Benson DW; Kornegay JN; Markham LW
    Pediatr Res; 2016 Apr; 79(4):629-36. PubMed ID: 26672735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy.
    Hui T; Jing H; Zhou T; Chen P; Liu Z; Dong X; Yan M; Ren D; Zou S; Wang S; Fei E; Hong D; Lai X
    Hum Mol Genet; 2021 Aug; 30(17):1579-1590. PubMed ID: 33987657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neurobiology of duchenne muscular dystrophy: learning lessons from muscle?
    Blake DJ; Kröger S
    Trends Neurosci; 2000 Mar; 23(3):92-9. PubMed ID: 10675908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients.
    Etienne J; Joanne P; Catelain C; Riveron S; Bayer AC; Lafable J; Punzon I; Blot S; Agbulut O; Vilquin JT
    J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1047-1069. PubMed ID: 32157826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
    Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
    Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy.
    Renzini A; Marroncelli N; Cavioli G; Di Francescantonio S; Forcina L; Lambridis A; Di Giorgio E; Valente S; Mai A; Brancolini C; Giampietri C; Magenta A; De Santa F; Adamo S; Coletti D; Moresi V
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1339-1359. PubMed ID: 35170869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy.
    Verma M; Shimizu-Motohashi Y; Asakura Y; Ennen JP; Bosco J; Zhou Z; Fong GH; Josiah S; Keefe D; Asakura A
    PLoS Genet; 2019 Dec; 15(12):e1008468. PubMed ID: 31877123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice.
    De la Garza-Rodea AS; Moore SA; Zamora-Pineda J; Hoffman EP; Mistry K; Kumar A; Strober JB; Zhao P; Suh JH; Saba JD
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial impacts of neuromuscular electrical stimulation on muscle structure and function in the zebrafish model of Duchenne muscular dystrophy.
    Kilroy EA; Ignacz AC; Brann KL; Schaffer CE; Varney D; Alrowaished SS; Silknitter KJ; Miner JN; Almaghasilah A; Spellen TL; Lewis AD; Tilbury K; King BL; Kelley JB; Henry CA
    Elife; 2022 Mar; 11():. PubMed ID: 35324428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.